Status:
TERMINATED
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
Lead Sponsor:
University of Florida
Conditions:
Transplantation, Kidney
Cardiovascular Abnormalities
Eligibility:
All Genders
18-80 years
Brief Summary
We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of ...
Detailed Description
Coronary disease is one of the most common causes of morbidity and mortality in patients with known chronic renal insufficiency and those with end stage renal disease. Consequently, early detection wi...
Eligibility Criteria
Inclusion
- kidney transplant recipients
- kidney/pancreas transplant recipients
- age 18-80
Exclusion
- inability to return for follow-up visits
- multiple organ transplant other than listed above
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00365833
Start Date
July 1 2006
End Date
February 1 2007
Last Update
September 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610